We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Commission for Patient and Public Involvement in Health (CPPIH) was established in January 2003 to set up and support Patients’ Forums. This independent, non-departmental public body (NDPB) was abolished on the 31st March 2008 when Patients’ Forums were replaced...
How to use an ethnographic study to evaluate your digital health product.
The MHRA has today set out its strategic approach to artificial intelligence (AI)
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
How to package medicines for sale and what information you must provide to consumers and healthcare professionals.
Information for NHS patients and service users.
Information and guidance on a range of medical devices for users and patients.
Forms and guidance for professionals working with restricted patients (mentally disordered offenders).
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
Consumers and patient groups are invited to submit evidence of their experience
An annual publication providing statistics on restricted patients in England and Wales
In October 2011 the NHS National Quality Board (NQB) agreed on a working definition of patient experience to guide the measurement of patient experience across the NHS.
Guidance, key documents, and CMA decisions on the review of PPU arrangements under the Private Healthcare Market Investigation Order 2014.
National Patient Safety Alerts (NatPSAs) are official notices giving instructions to NHS bodies on how to prevent risks which might cause serious harm or death.
This document explains: how patients are tested and treated, and steps in place to prevent its spread.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.